{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T13:19:58Z","timestamp":1725542398821},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,6,1]]},"DOI":"10.1093\/ndt\/15.6.755","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:37:35Z","timestamp":1027723055000},"page":"755-758","source":"Crossref","is-referenced-by-count":13,"title":["Sympathetic overactivity in renal failure controlled by ACE inhibition: clinical significance"],"prefix":"10.1093","volume":"15","author":[{"given":"Peter J.","family":"Blankestijn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry","family":"Ligtenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge H. H. T.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein A.","family":"Koomans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,6]]},"reference":[{"key":"key\n\t\t\t\t20180109101530_R1","doi-asserted-by":"crossref","unstructured":"Ligtenberg G, Blankestijn PJ, Oey PL et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med1999; 340: 1321\u20131328","DOI":"10.1056\/NEJM199904293401704"},{"key":"key\n\t\t\t\t20180109101530_R2","doi-asserted-by":"crossref","unstructured":"Ritz E, Koomans HA. New insights into mechanisms of blood pressure regulation in patients with uraemia. Nephrol Dial Transplant1996; 11 [Suppl 2]: 52\u201359","DOI":"10.1093\/ndt\/11.supp2.52"},{"key":"key\n\t\t\t\t20180109101530_R3","doi-asserted-by":"crossref","unstructured":"Campese VM. Neurogenic factors and hypertension in chronic renal failure. J Nephrol1997; 10: 184\u2013187","DOI":"10.1016\/S0895-7061(97)88673-6"},{"key":"key\n\t\t\t\t20180109101530_R4","doi-asserted-by":"crossref","unstructured":"Levitan D, Massry SG, Romoff M, Campese VM. Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: effect of clonidine. Nephron1984; 36: 24\u201329","DOI":"10.1159\/000183111"},{"key":"key\n\t\t\t\t20180109101530_R5","doi-asserted-by":"crossref","unstructured":"Laederach K, Weidmann P. Plasma and urinary catecholamines as related to renal function in man. Kidney Int1987; 31: 107\u2013111","DOI":"10.1038\/ki.1987.16"},{"key":"key\n\t\t\t\t20180109101530_R6","doi-asserted-by":"crossref","unstructured":"Converse RL, Jacobsen TN, Toto R et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med1992; 327: 1912\u20131918","DOI":"10.1056\/NEJM199212313272704"},{"key":"key\n\t\t\t\t20180109101530_R7","unstructured":"Klein IHHT, Oey PL, Ligtenberg G, Koomans HA, Blankestijn PJ. Muscle sympathetic nerve activity is increased in patients with early polycystic kidney disease. J Am Soc Nephrol1999; 10: 79A (abstract)"},{"key":"key\n\t\t\t\t20180109101530_R8","doi-asserted-by":"crossref","unstructured":"Schalekamp MADH, Schalekamp\u2010Kuyken MPA, de Moor\u2010Fruytier M, Meininger T, Vaandrager\u2010Kranenburg DJ, Birkenhager WH. Interrelationships between blood pressure, renin, renin substrate and blood volume in terminal renal failure. Clin Sci Mol Med1973; 45: 417\u2013428","DOI":"10.1042\/cs0450417"},{"key":"key\n\t\t\t\t20180109101530_R9","doi-asserted-by":"crossref","unstructured":"Weidmann P, Maxweel MH, Lupu AN, Lewin AJ, Massry SG. Plasma renin activity and blood pressure in terminal renal failure. N Engl J Med1971; 285: 757\u2013762","DOI":"10.1056\/NEJM197109302851401"},{"key":"key\n\t\t\t\t20180109101530_R10","doi-asserted-by":"crossref","unstructured":"Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreflexes in regulation of blood pressure. Am J Physiol1992; 262: E763\u2013778","DOI":"10.1152\/ajpendo.1992.262.6.E763"},{"key":"key\n\t\t\t\t20180109101530_R11","doi-asserted-by":"crossref","unstructured":"Matsukawa T, Gotoh E, Minamisawa K et al. Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am J Physiol1991; 30: R690\u2013696","DOI":"10.1152\/ajpregu.1991.261.3.R690"},{"key":"key\n\t\t\t\t20180109101530_R12","doi-asserted-by":"crossref","unstructured":"Rump LC. Advantages of Ang\u2010II receptor blockade over ACE inhibition with respect to suppression of sympathetic activity: heartening news for the kidney? Nephrol Dial Transplant1999; 14: 556\u2013559","DOI":"10.1093\/ndt\/14.3.556"},{"key":"key\n\t\t\t\t20180109101530_R13","doi-asserted-by":"crossref","unstructured":"Katholi RE, Whitlow PL, Hageman GR, Woods WT. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertens1984; 2: 349\u2013359","DOI":"10.1097\/00004872-198402040-00005"},{"key":"key\n\t\t\t\t20180109101530_R14","doi-asserted-by":"crossref","unstructured":"Faber JE, Brody MJ. Afferent renal nerve\u2010dependent hypertension following acute renal artery stenosis in the conscious rat. Circ Res1985; 57: 676\u2013688","DOI":"10.1161\/01.RES.57.5.676"},{"key":"key\n\t\t\t\t20180109101530_R15","doi-asserted-by":"crossref","unstructured":"Campese VM, Kogosow E, Koss M. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension1995; 25: 878\u2013882","DOI":"10.1161\/01.HYP.25.4.878"},{"key":"key\n\t\t\t\t20180109101530_R16","doi-asserted-by":"crossref","unstructured":"Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int1997; 51: 722\u2013727","DOI":"10.1038\/ki.1997.103"},{"key":"key\n\t\t\t\t20180109101530_R17","doi-asserted-by":"crossref","unstructured":"Miyajima E, Yamada Y, Yoshida Y et al. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension1991; 17: 1057\u20131062","DOI":"10.1161\/01.HYP.17.6.1057"},{"key":"key\n\t\t\t\t20180109101530_R18","doi-asserted-by":"crossref","unstructured":"Grassi G, Cattaneo BM, Seravalle G et al. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation1997; 96: 1173\u20131179","DOI":"10.1161\/01.CIR.96.4.1173"},{"key":"key\n\t\t\t\t20180109101530_R19","doi-asserted-by":"crossref","unstructured":"Grassi G, Turri C, Dell'Oro R, Stella ML, Bolla GB, Mancia G. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. J Hypertens1998; 16: 1789\u20131796","DOI":"10.1097\/00004872-199816120-00012"},{"key":"key\n\t\t\t\t20180109101530_R20","doi-asserted-by":"crossref","unstructured":"Schohn D, Weidmann P, Jahn H, Beretta\u2010Piccoli C. Norepinephrine related mechanisms in hypertension accompanying renal failure. Kidney Int1985; 28: 814\u2013822","DOI":"10.1038\/ki.1985.203"},{"key":"key\n\t\t\t\t20180109101530_R21","doi-asserted-by":"crossref","unstructured":"Julius S. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension1993; 21: 886\u2013893","DOI":"10.1161\/01.HYP.21.6.886"},{"key":"key\n\t\t\t\t20180109101530_R22","doi-asserted-by":"crossref","unstructured":"Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Circulation1999; 34: 724\u2013728","DOI":"10.1161\/01.HYP.34.4.724"},{"key":"key\n\t\t\t\t20180109101530_R23","unstructured":"Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A for the V\u2010HeFT VA Cooperative Studies Group. Plasma norepinephrine, plasma renin activity, and congestive heart failure: relations to survival and the effects of therapy in V\u2010HeFT II. Circulation1993; 87: VI\u201040\u2013VI\u201048"},{"key":"key\n\t\t\t\t20180109101530_R24","doi-asserted-by":"crossref","unstructured":"London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance and wave reflection in end stage renal disease: comparative effects of ACE inhibition and calcium channel blockade. Circulation1994; 90: 2786\u20132796","DOI":"10.1161\/01.CIR.90.6.2786"},{"key":"key\n\t\t\t\t20180109101530_R25","doi-asserted-by":"crossref","unstructured":"Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med1981; 304: 930\u2013933","DOI":"10.1056\/NEJM198104163041602"},{"key":"key\n\t\t\t\t20180109101530_R26","doi-asserted-by":"crossref","unstructured":"Fletcher EC, Bao G, Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension1999; 34: 309\u2013314","DOI":"10.1161\/01.HYP.34.2.309"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/15\/6\/755\/23367494\/150755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T08:48:38Z","timestamp":1583311718000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/15\/6\/755\/1858434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6,1]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2000,6]]},"published-print":{"date-parts":[[2000,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/15.6.755","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,6]]},"published":{"date-parts":[[2000,6,1]]}}}